Hippocampal atrophy is one of the earliest biomarkers of AD, and the APOE ε4 status has been associated with smaller hippocampi among cognitively healthy middle-aged and older adults (den Heijer et al., 2002; Taylor et al., 2014). This evidence concerns the gene APOE and Alzheimer disease.